Britain to infect healthy volunteers to speed up COVID-19 vaccine efforts

Britain signed a contract with Open Orphan and its London-based unit, hVivo, that paves the way for human challenge trials, the company said on Tuesday. The plan is to manufacture the virus and conduct a study to determine how much of the pathogen to expose volunteers to in the trials.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news